ROCHESTER, Minn., Jan. 22 (UPI) -- Certain measles virus vaccine strain derivatives may prove an effective treatment for patients with advanced prostate cancer, U.S. researchers said.
LONDON, July 22 (UPI) -- The Phase 1 clinical trial of the drug abiraterone revealed significant tumor shrinkage in men with advanced prostate cancer, researchers in Britain said.
LOS ANGELES, Feb. 1 (UPI) -- University of Southern California researchers have developed a vaccine that prevented cancer in 90 mice genetically predestined for prostate cancer.
PHILADELPHIA, Jan. 1 (UPI) -- U.S. scientists have found a protein that seems key to turning on a recurrent prostate cancer that is resistant to hormone therapy.
TOKYO, March 16 (UPI) -- The largest study looking at soy-rich diets and the development of prostate cancer in Japanese men has resulted in seemingly contradictory conclusions.
MADISON, Wis., Nov. 8 (UPI) -- U.S. scientists have discovered a specific biochemical pathway involved in the development of prostate cancer.
SOUTH SAN FRANCISCO, Calif., July 5 (UPI) -- Cell Genesys said Wednesday data from a phase 1/2 trial show its prostate cancer vaccine GVAX induces immune responses.
WASHINGTON, June 24 (UPI) -- A new study indicates a drug used to fight baldness and enlarged prostates also increases protection against prostate cancer.
GRENOBLE, France, July 11 (UPI) -- Suppressing a male hormone associated with prostate cancer could increase an advanced prostate cancer patient's chances of living free of the disease substantially, but the therapy comes with some strong side effects, researchers report.
DURHAM, N.C., Jan. 30 (UPI) -- A new study in its early phase suggests a cancer vaccine made with prostate cancer patients' own cells is safe and effectively triggers an immune system attack on the tumor. Dr. Johannes Vieweg of Duke University Medical Center tested the experimental vac
